The world's first underwater hydro-vacuum massage system.
Recovery reimagined, at scale. A multi-utility wellness platform delivering structured full-body recovery, muscle conditioning, and body toning, built for commercial performance.
The outcomes clients want have never come from one platform.
High-performing individuals, athletes, and premium wellness consumers want full-body recovery, muscle conditioning, and body toning, outcomes that have never been available from a single platform.
No all-in-one solution exists
Clients cobble together multiple providers and multiple appointments, with no guarantee the combined result adds up to what they actually need.
Results are inconsistent and unpredictable
Outcome quality depends on who you book, not the protocol you receive. Quality cannot be standardized, replicated, or scaled efficiently.
Results are felt, not measured
Outcomes are self-reported and rarely tied to a protocol. Operators have no system to capture progress, see what works, or prove value with data.
The economics punish everyone
Multi-device stacks demand heavy CapEx, specialist staff, and complex scheduling. Clients pay for fragmented care at fragmented prices.
A new demand wave is here, and nothing is built to serve it.
A new recovery demand wave
20M+ active GLP-1 users in the US, growing ~30% a year. Rapid weight loss drives muscle deterioration, skin laxity, and compromised body composition, exactly the muscle reconditioning, toning, lymphatic support, and skin firming AquaTornado delivers.
Performance wellness goes mainstream
Biohacking, longevity, and active recovery have moved from elite sport into everyday consumer culture. The US MedSpa market is $7.4B (2025), growing 13.7% CAGR, with body contouring and recovery leading.
Operators are hungry for differentiation
The luxury MedSpa and premium studio boom has created a motivated B2B buyer with capital, seeking high-margin technology that reduces skilled-labor dependence and creates recurring revenue.
One platform. Three outcomes. Zero compromise.
AquaTornado is a multi-utility, protocol-driven wellness platform delivering structured full-body recovery, muscle conditioning, and body toning, standardized, scalable, and designed to reduce skilled-labor dependence.
Hydro-vacuum therapy reaches a depth and intensity manual treatment cannot. In 45–60 minutes it clears metabolic waste, reduces inflammation, and restores muscle tissue.
Targeted hydro-pressure and vacuum protocols stimulate deep muscle activation and toning, a conditioning stimulus between workouts without the soreness or a recovery day.
Precision body contouring improves skin firmness, reduces cellulite appearance, and optimizes lymphatic drainage, aesthetic outcomes alongside functional recovery.
Multi-utility architecture, built for commercial scale.
Multi-utility architecture
45–60 minute sessions covering recovery, conditioning, and toning. Configurable protocols support athletic recovery, body contouring, and high-performance wellness, all from one platform.
Wellness-first framework
Supports weight management, circulation, lymphatic flow, muscle recovery, and toning, real performance outcomes without diagnostic or pharmaceutical claims.
Built for commercial scale
One trained operator per session, no clinical license. Device-driven, standardized protocols mean any trained staff delivers the same outcome, faster hiring, lower labor cost, unlimited scalability.
AI-guided personalization
AI adapts session parameters to client profiles, outcome history, and real-time biofeedback. The next layer, not a dependency for Day-1 operations.
Client Check-In
Staff or kiosk intake. AI-prompted protocol selected from client profile and goals.
Session Activation
Platform initializes. Hydro-vacuum activates across treatment zones.
Protocol Execution
45–60 min multi-zone session: recovery, conditioning, toning, or a combined flow.
Session Debrief
Outcome logged. Follow-up recommended. AI refines the next session.
Category creation, not competition.
AquaTornado does not compete with any single recovery or body-contouring device. It creates an entirely new category, the only multi-utility, protocol-driven platform in premium wellness.
Structural IP moat
US utility patents (provisional filed), design patents, trade secrets, and trademark. Prosecution ongoing across USA, Canada, EU, and UAE. The hydro-vacuum mechanism, protocol system, and hardware architecture are proprietary.
Multi-utility economics
One platform replaces a stack of single-indication devices, massage, EMS, red light, vibration, body contouring. Multi-utility creates multi-revenue from a single CapEx investment.
Protocol-driven scalability
RMT and osteopathy need licensed practitioners at $80–200/hr. AquaTornado runs the same 1:1 ratio with trained device operators, not licensed therapists. Quality scales with the hardware, not the hire.
Operator-first business design
Purpose-built for medspas, studios, recovery centers, and hotel spas. Trainable operators improve margins; recurring revenue (10% of ASP/yr); ~31-month operator payback at mature utilization.
The only multi-utility platform in the category.
| Modality / Competitor | Session price | Labor req. | Throughput | Operator ROI | Multi-utility |
|---|---|---|---|---|---|
| RMT / Osteopathy | $80–200 | 1:1 (therapist) | 1 client / hr | Low, wage-capped | No |
| EMS Bodysuit (in-clinic) | $50–150 | 1 trainer / client | 1–2 / hr | Moderate (home use competes) | No |
| Cryotherapy | $50–100 | 1 operator / session | 3–4 / hr | Moderate (low ASP) | No |
| Red Light Therapy | $25–50 | Minimal supervision | 4–6 / hr | Moderate (home use competes) | No |
| Emsculpt NEO | $750–1,500 | 1 tech / patient | 2 / hr per device | High / session; ~40 mo payback | Body contouring only |
| HydroMassage Pod | $30–60 | Minimal | 2–3 / hr | Low (low price point) | No |
| AquaTornado | $300 | 1:1 trained operator | 8 sessions / day | ~31 mo payback @ 70% | Recovery + Conditioning + Toning |
Competitor pricing, labor, and throughput are market estimates and vary by location and utilization. AquaTornado figures are derived from the company financial model. Operator ROI reflects payback at mature utilization.
One specific, high-growth market, not a proxy for global wellness.
- TAM, $21B: global MedSpa market (2025), $7.4B in the US. Body contouring, active recovery, and GLP-1 aftercare lead growth at 13.7% CAGR, $17.6B US by 2030.
- SAM, $3.5B: premium in-clinic recovery & body contouring (~$2.2–2.6B US contouring + ~$500M premium recovery + ~$500M UAE/EU). ~20–25% of 15,000 US medspas are premium-tier.
- SOM, ~$100M: 3% of ~4,000 premium global operators = ~120 relationships by Year 5. The Year-5 base case ($64.8M) sits at 1.8% SAM penetration, the model is validated by, not driving, this.
Context: 126M+ Americans have musculoskeletal conditions and 42% of US adults are overweight or obese. The medspa channel is our primary commercial vehicle.
The addressable condition burden is vast.
A non-invasive wellness platform (not a medical device), with no clinical efficacy claims. The populations below are actively seeking non-invasive recovery and body wellness, and their scale defines commercial demand.
Musculoskeletal
- Chronic low back pain (619M global)
- Osteoarthritis (58M US)
- Fibromyalgia, strains & sprains
- Plantar fasciitis, tendinopathies
- Post-activity soreness
- Postural & mobility concerns
Body composition
- Body contouring & toning
- Cellulite (~90% of women)
- Skin laxity & tissue firming
- Post-partum restoration
- Weight-management support
- Pre / post-event prep
Lymphatic & circulatory
- Lymphatic drainage support
- Chronic venous insufficiency
- Peripheral edema, fluid retention
- Poor circulation (sedentary)
- DOMS & overtraining recovery
- Stress-related muscle tension
Performance & athletic
- Athletic recovery & regeneration
- Return-to-activity support
- Pre-competition priming
- Neuromuscular conditioning
- Endurance recovery
- Executive & corporate wellness
What is defensible, and why it matters.
- Proprietary hydro-vacuum mechanism
- Full-body zones, precision pressure
- Integrated session sensors
- Modular upgrade path
- Standardized protocol library
- Operator dashboard & analytics
- Client config & outcome tracking
- Remote update & monitoring
- Single-use hygiene liners
- Disposable applicator components
- Per-session recurring revenue
- Device-specific, sourced via AQT
- AI personalization engine
- Outcome data across locations
- Predictive session optimization
- Proprietary dataset compounds
Three revenue pillars, one flywheel.
Direct Device Sales
Hardware margin ~54.5% (Yr 1) → ~66.2% (Yr 5). 10% / 15% volume discounts. 80% service attach post-Yr 1 (10% of ASP/yr). Targets: luxury spas, sports teams, hotels, VIP clients.
Franchise Studios
$75K initial fee, ~$1.1M franchise CapEx. Scale 0 → 33 studios by Yr 5, contributing ~$12.8M in franchise revenue to AQT in Year 5.
Company-Owned Flagships
$3M CapEx, 5 platforms each, ~53% contribution at maturity. 10 company-owned locations by Yr 5. Proves the concept and drives demand.
Recurring revenue scales to ~25–30% of total every year (~$0.4M in 2027 → ~$19.5M in 2031), driven by service contracts, franchise royalties, and per-session consumables.
Per-platform economics, from ramp to mature.
8 sessions/day × $300 × 26 days = $748,800 max annual capacity per platform; 5 platforms per studio. Three utilization milestones:
Seed capital is designed to fund this ramp period.
Positive monthly contribution, trending to maturity.
Strong repeat clientele. Compelling operator payback.
From $1.8M to $64.8M, at a 48% EBITDA margin.
Revenue by stream
EBITDA & margin
2031 revenue mix
What moves the needle, and by how much.
| Scenario | 5-Yr revenue | 5-Yr EBITDA | Yr-5 margin |
|---|---|---|---|
| Base case | $125.5M | $49.4M | 48.3% |
| Downside −15% | $106.7M | $34.8M | 42.8% |
| Upside +15% | $144.3M | $64.1M | 52.4% |
| Util ↓ / Studios → | 7 | 9 | 11 | 13 |
|---|---|---|---|---|
| 30% | 16,814 | 16,388 | 15,961 | 15,534 |
| 50% | 21,689 | 22,655 | 23,621 | 24,587 |
| 70% | 26,564 | 28,922 | 31,281 | 33,640 |
Base case: 11 studios at 70% utilization. OpEx held at base; only the revenue line is scaled per scenario.
Prove with athletes first. Scale B2B second.
Flagship Activation
5–8 platforms per studio. Onboard elite athletes and influencers. Intentional scarcity drives premium positioning and inbound demand.
Operator Demand Capture
Flagship proof drives the inbound B2B pipeline. Controlled hardware sales (3–5 unit packages). Franchise launch: first 2–4 studios. Financing accelerates adoption.
Global Scale
New York, Riyadh and second-tier markets. Franchise scaling 10–15 studios/yr by Year 4–5. Recurring revenue compounds. AI layer deployed network-wide.
The athlete-to-consumer playbook is proven
NormaTec (97% of US pro sports) → Hyperice (NBA partner) → Emsculpt NEO (NFL + Olympic). $2M of seed funds athlete onboarding and influencer seeding in Year 1, the fastest route to premium adoption and category-defining positioning.
$7.5M across five priorities: launch, team, IP, and market.
Flagship buildout: leasehold ~$1.5M, buildout $500K, equipment & furniture $500K, launch $500K. Athlete marketing tapers to $1M in Year 2. Total seed raise: $7.5M.
The team behind AquaTornado.
Deep scientific expertise, operational experience, and healthcare and regulatory knowledge, combined under one roof.
CEO / Founder
Strategic vision, fundraising, commercial partnerships.
Operations Lead
Studio operations, supply chain, protocol execution.
Sales Director
B2B pipeline, franchise development, operator sales.
Technology Lead
Platform architecture, software, AI personalization.
Finance Lead
Financial modeling, investor relations, compliance.
Scientific Advisor
Clinical validation, MSK expertise, outcomes research.
$7.5M Seed at $75M post-money.
Raising to scale a platform with proven demand, not to validate an idea. A higher-end seed justified by a working product.
- Seed preferred equity at $75M post-money
- Capital deploys: flagship Dubai + team + IP + athlete marketing
- Exit: strategic acquisition, IPO, or long-term platform scale
- Comparable wellness platforms exit at 5–12× revenue
Exit · Year-5 base case
Yr-5 base case: $64.8M revenue, $31.3M EBITDA (48% margin). MOIC range 4.5–10.6×. Early investors enter at category-creation pricing.
Not raising to validate an idea. Raising to scale a platform.
Proven unit economics · recurring revenue architecture · structural IP defensibility across hardware, protocol, and software · a category-defining position in a $21B and growing global MedSpa market, accelerated by a 20M+ GLP-1 wave creating urgent new demand for exactly what AquaTornado delivers.
Three flagship cities. Three major markets. One platform designed to own a category.